Now available
Be the first to detect COVID VOCs with hpPCR
SARS-CoV-2 Omicron BA.2
SARS-CoV-2 Omicron BA.2.12.1
SARS-CoV-2 Omicron BA.4/BA.5
And why not
Influenza A/B & RSV-A/B at the same time?
VISION
The ultimate diagnostic solution, available to everyone
We strongly believe in a future where advanced molecular testing is available to everyone. Our technology enables unparallelled degree of insights using simple routine workflows. Thanks to our novel nano- & biochemistry, this is achieved without the need for complex instrumentation, meaning that any lab can get started without large up-front costs.
Hyperplexed hpPCR
For over 30 years PCR has been the gold standard to achieve specific and sensitive nucleic acid detection, serving as a powerful diagnostic tool in the current pandemic. However, when a high number of pathogens/variants need to be detected in a single sample, costly and labor intensive NGS is still the main alternative.
We introduce the next-generation of PCR with ultra-sensitivity, specificity and hyperplexing. The hpPCR assay enables single molecule detection of up to 100 pathogens/variants in a single tube eliminating the need for sequencing. Results can be achieved within 3h.
Sensitivity, specificity, multiplexity. No compromises.
WHY APLEX BIO
Full molecular snapshot of any biological sample
Today only a fraction of information is collected from patient samples. Our vision is to allow all information to be precisely collected, every time.
No more delays in diagnostics. No more bias.
INDUSTRY
Our
Partners
Our partners involved in supporting us on our journey.
Breakthrough early detection of Omicron BA.2 in wastewater achieved with hpPCR
13 apr. 2022
APLEX Bio raises 14 MSEK (€1.3M) for development of its next-generation hyperplexed molecular detection technology
11 mars 2022